Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Exkivity is suitable for specific non-small cell lung cancer(NSCLC).【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：6
Broad-spectrum antitumor agents【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：1
Ixazomab is suitable for the treatment of multiple myeloma.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：17
It is mainly used for the treatment of chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL) and certain types of acute myeloid leukaemia (AML).【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：8
Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：5
司帕生坦、Sparsentan、LuciSeta、Filspari、斯帕森坦【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：8
Suitable for treating severe alopecia areata in adults and adolescents aged 12 and above.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：0
Used for the treatment of advanced, unresectable cholangiocarcinoma with FGFR2 gene fusion or rearrangement.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：3
Treat RET gene fusion positive NSCLC and MTC.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：16
Treat non-small cell lung cancer, medullary thyroid carcinoma, and thyroid cancer caused by RET gene mutations.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：4
Enasidenib is suitable for Leukemia.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：18
Androcur can inhibit the action of androgens and treat diseases caused by excessive androgens.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：4
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：672025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：3672024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：602025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：802025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：742025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：942025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：902025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：932025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
